Clinical trials
Phase 2 Glaucoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
84 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 4 |
| 2008 | 1 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 8 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 11 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
| Unknown status | 4 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Aerie Pharmaceuticals | 9 |
| Alcon Research | 9 |
| Mati Therapeutics Inc. | 8 |
| Qlaris Bio, Inc. | 7 |
| Allergan | 4 |
| Santen Inc. | 4 |
| Amakem, NV | 2 |
| Christopher Kai Shun Leung | 2 |
| Hoffmann-La Roche | 2 |
| Inotek Pharmaceuticals Corporation | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 84 |
| Ocular Hypertension | 51 |
| Glaucoma, Open-Angle | 34 |
| Hypertension | 6 |
| Eye Diseases | 3 |
| Low Tension Glaucoma | 3 |
| Sturge-Weber Syndrome | 3 |
| Epilepsy | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
Trials
Showing 76 to 84 of 84. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.